The Top Line

Available every Friday morning, The Top Line podcast will recap the biggest news and why it matters—from mergers and marketing to drug R&D and device development.

Biotech

Fierce Biotech's top 10 editor's picks for 2024

From the conference circuit to the Nasdaq trading floor, we run down some of the highlights from Fierce Biotech's coverage this year.

James Waldron Dec 23, 2024 3:00am

What can we learn from 2024’s biotech IPOs?

Dec 6, 2024 8:44am

Misconduct and the future of neurodegenerative disease research

Nov 15, 2024 9:06am

Dig into this year’s Fierce Biotech Graveyard, layoff numbers

Nov 8, 2024 9:44am

Where are they now? Catching up with past Fierce 15 honorees

Oct 18, 2024 9:39am

A closer look at Fierce Biotech's Fierce 15

Aug 9, 2024 9:16am